Screener
West Pharmaceutical Services WST Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by West Pharmaceutical Services in its filing.
Tagged under the XBRL concept us-gaap:OtherOperatingIncomeExpenseNet.
The source filing: West Pharmaceutical Services’s 10-Q, filed July 23, 2026.
- Filed
- Jul 23, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000105770-26-000099
| ($ in millions) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Restructuring and related charges | $2.3 | $0.2 | $4.1 | $16.6 |
| Contingent consideration | 3.2 | 2.2 | 6.2 | 4.6 |
| Asset impairments | 3.9 | 0.8 | 4.2 | 1.1 |
| Foreign exchange transaction losses | 1.9 | 1.7 | 3.0 | 2.9 |
| (Gain) loss on oil hedges | 1.0 | 0.2 | (0.9) | 0.4 |
| Other items | 0.5 | 0.1 | 0.2 | 0.2 |
| Total other expense (income) | $12.8 | $5.2 | $16.8 | $25.8 |
Item 1. FINANCIAL STATEMENTS (UNAUDITED)
FAQ
- What is West Pharmaceutical Services's other operating expenses?
- West Pharmaceutical Services (WST) reported other operating expenses of -$500K in Q2 2026.
- How has West Pharmaceutical Services's other operating expenses changed year-over-year?
- West Pharmaceutical Services's other operating expenses decreased by 400.0% year-over-year, from -$100K to -$500K.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.
Ask your AI about West Pharmaceutical Services's other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude